173 related articles for article (PubMed ID: 12480922)
1. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
Menon AG; Morreau H; Tollenaar RA; Alphenaar E; Van Puijenbroek M; Putter H; Janssen-Van Rhijn CM; Van De Velde CJ; Fleuren GJ; Kuppen PJ
Lab Invest; 2002 Dec; 82(12):1725-33. PubMed ID: 12480922
[TBL] [Abstract][Full Text] [Related]
2. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
[TBL] [Abstract][Full Text] [Related]
3. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
Menon AG; Janssen-van Rhijn CM; Morreau H; Putter H; Tollenaar RA; van de Velde CJ; Fleuren GJ; Kuppen PJ
Lab Invest; 2004 Apr; 84(4):493-501. PubMed ID: 14968119
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
[TBL] [Abstract][Full Text] [Related]
5. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
Karahan B; Argon A; Yıldırım M; Vardar E
Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
[TBL] [Abstract][Full Text] [Related]
6. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of human leukocyte antigen Class I expression: An independent prognostic factor in colorectal cancer.
Nazemalhosseini-Mojarad E; Asadzadeh-Aghdaei H; Mohammadpour S; Esfahani AT; Porhoseingholi MA; Molaei M; Jalali A; K Kuppen PJ; Zali MR
J Cancer Res Ther; 2020 Dec; 16(Supplement):S165-S171. PubMed ID: 33380672
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.
Leffers N; Gooden MJ; Mokhova AA; Kast WM; Boezen HM; Ten Hoor KA; Hollema H; Daemen T; van der Zee AG; Nijman HW
Gynecol Oncol; 2009 May; 113(2):256-63. PubMed ID: 19243813
[TBL] [Abstract][Full Text] [Related]
10. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
11. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
[TBL] [Abstract][Full Text] [Related]
12. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
13. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.
Kloor M; Becker C; Benner A; Woerner SM; Gebert J; Ferrone S; von Knebel Doeberitz M
Cancer Res; 2005 Jul; 65(14):6418-24. PubMed ID: 16024646
[TBL] [Abstract][Full Text] [Related]
14. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
Benevolo M; Mottolese M; Piperno G; Sperduti I; Cione A; Sibilio L; Martayan A; Donnorso RP; Cosimelli M; Giacomini P
Am J Surg Pathol; 2007 Jan; 31(1):76-84. PubMed ID: 17197922
[TBL] [Abstract][Full Text] [Related]
15. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.
Walsh MD; Dent OF; Young JP; Wright CM; Barker MA; Leggett BA; Bokey L; Chapuis PH; Jass JR; Macdonald GA
Int J Cancer; 2009 Sep; 125(5):1231-7. PubMed ID: 19462453
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity.
Bernal M; Concha A; Sáenz-López P; Rodríguez AI; Cabrera T; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2011 Jun; 60(6):869-82. PubMed ID: 21400022
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
[TBL] [Abstract][Full Text] [Related]
19. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M
Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer.
Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D
Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
